Delivery Order 75N94020D00004-75N94023F00001
Award Date 9/28/23
Potential Completion Date 11/30/25
Potential Value $126K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Roxbury, MA 02118, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
16
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $719,094.93 federal contract award to Boston Medical Center Corporation (BMC) by the National Institute of Child Health and Human Development (NICHD), a civilian agency. The contract is for a Phase 2B study to evaluate the efficacy and safety of subcutaneous levonorgestrel butanoate for female contraception. This is a non-severable task order under a larger R&D contract. The contract is a delivery order with a cost-no-fee pricing type and has no set-aside designation, indicating...
- Boston Medical Center Corporation was awarded a $108,311.84 cost-no-fee delivery order against the Contraceptive Clinical Trials Network-Female Sites contract vehicle by the Department of Health and Human Services' National Institutes of Health National Institute of Child Health and Human Development. This delivery order calls for BMC to provide assistance in protocol review, protocol development, and other activities associated with the past, present, and future of the Contraceptive Clinical...
- Boston Medical Center Corporation is providing clinical trial network services under a $678,333 delivery order against the Contraceptive Clinical Trials Network-Female Sites contract vehicle through the National Institutes of Health National Institute of Child Health and Human Development. As the prime contractor, BMC will support the Evaluation of LARCs Study as a clinical research site. No set-aside designation was applied to this order to evaluate long-acting reversible contraceptive methods....
- This is a $15,589.93 firm-fixed-price delivery order awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services (HHS), to Boston Medical Center Corporation (BMC), a non-profit academic medical center in Boston, Massachusetts. The contract is for CPTAC (Clinical Proteomic Tumor Analysis Consortium) task order services and does not have a set-aside designation. The order is part of a larger NCI Tissue Source Site for Tumor Analysis indefinite...
- The National Institute of Child Health and Human Development (NICHD), a civilian federal agency, has awarded a $43,865.00 delivery order contract to The Regents of the University of California, San Francisco (UCSF) for the "OVAPRENE PHASE 1: PROTOCOL FINALIZATION, REGULATORY APPROVAL, START-UP, AND COMMENCEMENT OF RECRUITMENT, SCREENING, AND ENROLLMENT FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL." This contract, which does not have a set-aside designation, supports activities...
- This is a $656,182 delivery order contract awarded by the National Institute of Child Health and Human Development (NICHD) to Old Dominion University, doing business as Evms Health Services, to conduct a non-severable CCTN LB Phase 2B clinical trial. The contract has an ultimate completion date of December 31, 2028 and is a cost-type contract with no fee. This award is part of a larger $5 million multiple-award indefinite delivery contract with NICHD's Contraceptive Development Program to...
- This federal contract award, with an ID of 75N94019D00004|75N94023F00003, was issued by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services. The $2,160,831.00 delivery order was awarded to Health Decisions, Inc., a for-profit organization, to provide services including finalization, procurement of regulatory approval, and complete start-up activities for the Ovaprene vaginal device clinical trial. This order...
- This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Beth Israel Deaconess Medical Center, Inc. (Bidmc), a non-profit academic medical center in Boston, Massachusetts. The contract has a ceiling value of $28,512 and is for the procurement of SOMASCAN 11K Array services, which involve specialized medical testing and research capabilities. The contract does not have a set-aside designation, indicating that Bidmc successfully competed...
- This federal contract award is for an "EDUCATION COST SHARING" effort awarded to Boston Medical Center Corporation (BMC), a major academic medical center and safety-net hospital located in Boston, Massachusetts. The contract has a ceiling value of $944,048.09 and does not have a set-aside designation, indicating open competition. The contract is a definitive contract with a fixed price with economic price adjustment pricing type, awarded by the Veterans Integrated Service Network 1,...
- This is a delivery order awarded by the National Heart Lung and Blood Institute, a component of the National Institutes of Health, to Trustees of Boston University (doing business as Boston University Medical Campus) for the Framingham Heart Study. The contract has a ceiling value of $1,624,281.00 and is for the Year 4 Basic Exam of Task Area B, with a period of performance through April 30, 2023. The contract is a cost-type arrangement with no fee and does not have a set-aside designation....